• Profile
Close

TNFα and IL-17A are differentially expressed in psoriasis-like vs. eczema-like drug reactions to TNF antagonists

Journal of Cutaneous Pathology Oct 13, 2017

Deubelbeiss C, et al. - This study pursued a comparative scrutiny of the expression of tumor necrosis factor alpha (TNFα) and IL-17A in psoriasis-like with eczema-like drug reactions to TNF antagonists. Both TNFα and IL-17A exhibited an involvement in psoriasis but less so in non-psoriasiform dermatitis or eczema. Their overexpression in pustular like reactions (PPR) appeared to be plausible which indicated that the pathogenesis of PPR was similar at least in part, to those of psoriasis. In order to define the exact role of these cytokines in rare cutaneous side effects of anti-TNFα therapy additional analysis was required. It was inferred that IL-17A inhibition could serve a therapeutic option in patients with anti-TNF induced psoriasis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay